Literature DB >> 33911657

Pseudomyogenic Hemangioendothelioma in a 30-Year-Old Man: A Rare Case Report.

Chao-Yu Liao1, Chao-Kuei Juan1,2, Chi-Shun Yang3, Yi-Ju Chen1,2.   

Abstract

Entities:  

Year:  2019        PMID： 33911657      PMCID： PMC7992566          DOI： 10.5021/ad.2019.31.5.591

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN： 1013-9087            Impact factor:   1.444


× No keyword cloud information.
  5 in total

Review 1.  Pseudomyogenic Hemangioendothelioma: Case Report and Review of the Literature.

Authors:  Emily Raftopoulos; Michael Royer; Mildred Warren; Jin Zhao; Walter Rush
Journal:  Am J Dermatopathol       Date:  2018-08       Impact factor: 1.533

2.  Sirolimus therapy in the treatment of pseudomyogenic hemangioendothelioma.

Authors:  Krisztina Mita Gabor; Zoltan Sapi; Lilla Gyorgyi Tiszlavicz; Anita Fige; Csaba Bereczki; Katalin Bartyik
Journal:  Pediatr Blood Cancer       Date:  2017-08-26       Impact factor: 3.167

Review 3.  Pseudomyogenic hemangioendothelioma.

Authors:  Nicholas A Horan; Dominick J DiMaio
Journal:  Cutis       Date:  2017-12

4.  Telatinib Is an Effective Targeted Therapy for Pseudomyogenic Hemangioendothelioma.

Authors:  David G P van IJzendoorn; Stefan Sleijfer; Hans Gelderblom; Ferry A L M Eskens; Geert J L H van Leenders; Karoly Szuhai; Judith V M G Bovée
Journal:  Clin Cancer Res       Date:  2018-03-06       Impact factor: 12.531

5.  Cutaneous epithelioid sarcomalike (pseudomyogenic) hemangioendothelioma: a little-known low-grade cutaneous vascular neoplasm.

Authors:  Luis Requena; Carlos Santonja; Jose Luis Martinez-Amo; Carlos Saus; Heinz Kutzner
Journal:  JAMA Dermatol       Date:  2013-04       Impact factor: 10.282
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.